gene editing

Why Shares of Tango Therapeutics Climbed This Week
Why Shares of Tango Therapeutics Climbed This Week
Motley Fool
Tango Therapeutics
CRISPR
gene editing
clinical trials
Flag link:
Amber Bio Raises $26 Million Seed Financing to Advance New RNA-Based Gene Editing Platform
Amber Bio Raises $26 Million Seed Financing to Advance New RNA-Based Gene Editing Platform
Yahoo/Businesswire
Amber Bio
funding
gene editing
RNA
Flag link:
Gene editing biotech Homology hits reset and seeks a sale
Gene editing biotech Homology hits reset and seeks a sale
BioPharma Dive
Homology
PKU
gene editing
M&A
Flag link:
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
Forbes
Scribe Therapeutics
CRISPR
gene editing
Benjamin Oakes
Flag link:
Sanofi expands research deal with gene editing startup Scribe
Sanofi expands research deal with gene editing startup Scribe
BioPharma Dive
Sanofi
gene editing
Scribe Therapeutics
Flag link:
Pfizer pours $25M investment into Caribou's cell therapies
Pfizer pours $25M investment into Caribou's cell therapies
Fierce Biotech
Pfizer
Caribou Biosciences
gene editing
CAR-T
Multiple Myeloma
Flag link:
Verve partners with Lilly on gene editing therapy for heart disease
Verve partners with Lilly on gene editing therapy for heart disease
BioPharma Dive
Eli Lilly
Verve Therapeutics
heart disease
gene editing
Flag link:
Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
BioSpace
gene editing
Editas Medicine
Vertex Pharmaceuticals
CRISPR Therapeutics
EDIT-301
sickle cell disease
beta thalassemia
Flag link:
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
FDA
sickle cell disease
beta thalassemia
Flag link:
Bayer licenses lipid nanoparticle tech for gene therapy
Bayer licenses lipid nanoparticle tech for gene therapy
BioProcess International
Bayer
Acuitas Therapeutics
gene editing
Flag link:
Novo makes a gene editing move
Novo makes a gene editing move
EP Vantage
Novo Nordisk
gene editing
Life Edit Therapeutics
Flag link:
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
BioSpace
AstraZeneca
Revvity
gene editing
cell therapy
Flag link:
Gene Editing Therapeutics Could Hit the Market in 2023
Gene Editing Therapeutics Could Hit the Market in 2023
BioSpace
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia Therapeutics
Editas Medicine
Beam Therapeutics
Flag link:
Intellia Seeks to Broaden Gene Editing’s Potential with Full-Spectrum Approach
Intellia Seeks to Broaden Gene Editing’s Potential with Full-Spectrum Approach
BioSpace
gene editing
Intellia Therapeutics
Flag link:
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Endpoints
Vertex Pharmaceuticals
diabetes
CRISPR
gene editing
CRISPR Therapeutics
Flag link:
German biotech launches with ‘seamless’ gene editing platform built on evolving enzymes
German biotech launches with ‘seamless’ gene editing platform built on evolving enzymes
Endpoints
Seamless Therapeutics
gene editing
Flag link:
Novartis Drops SCD Gene Therapy Program with Intellia
Novartis Drops SCD Gene Therapy Program with Intellia
BioSpace
Novartis
sickle cell disease
Intellia Therapeutics
CRISPR
gene editing
Flag link:
Moderna's latest genomics move sees it team up with Life Edit to develop new gene editing therapies
Moderna's latest genomics move sees it team up with Life Edit to develop new gene editing therapies
Fierce Biotech
Moderna Therapeutics
genomics
MRNA
ElevateBio
Life Edit Therapeutics
gene editing
Flag link:
Study: Base Editing Shows Promise In Treating Heart Disease
Study: Base Editing Shows Promise In Treating Heart Disease
BioSpace
gene editing
base editing
heart disease
heart damage
Flag link:
Vertex Leans into Gene Editing Space with Extended Arbor Pact
Vertex Leans into Gene Editing Space with Extended Arbor Pact
BioSpace
Vertex Pharmaceuticals
Arbor Biotechnologies
gene editing
Flag link:

Pages